A recent Cedars-Sinai Cancer study found that up to 80 per cent of the time, patients with early pancreatic cancer are incorrectly staged. The discovery highlights the critical need for improvements in staging and diagnostic technology, which could have a substantial impact on early pancreat
Mostly because it is discovered much later in life, pancreatic cancer is one of the deadliest types of the disease. For screens aimed at early detection, the current markers are too ambiguous and insensitive. Now, a study team has published a novel technique in the journal Angewandte Chemie
Due in part to its frequent treatment resistance, pancreatic cancer is an especially aggressive and challenging malignancy to treat. This resistance is linked to the chemical composition of the surrounding tissue as well as the tissue's physical stiffness around the malignant cells, accordin
Pancreatic cancer is notorious for its late detection and high mortality rate, but a new Israeli approach to magnetic resonance imaging (MRI) that illuminates pancreatic tumors offers hope for earlier diagnoses and treatment.
Researchers have discovered a possible target for cancer immunotherapy. The research, directed by Professor Massimiliano Mazzone, discovered that the CDA gene is one of the most elevated metabolic genes in immunotherapy-resistant cancer. Inhibiting this gene through pharmacological or geneti
Mumbai-headquartered pharma major, Cipla's US arm has secured final approval from the United States Food and Drug Administration (USFDA) for its Lanreotide Injection 120 mg/0.5 mL, 90 mg/0.3 mL, and 60 mg/0.2 mL.
Liver inflammation, a typical side effect of malignancies elsewhere in the body, has long been associated with poor cancer outcomes and, more recently, with poor response to immunotherapy. A team of researchers from the University of Pennsylvania's Abramson Cancer Centre and Perelman School
Researchers have looked into the disappearance of pancreatic islet cells in people who have never suffered pancreatitis. They determined that the loss of insulin-producing beta cells was the primary cause of islet cell loss in the elderly after finding notable trends in the types of cells lo
Pancreatic cancer is difficult to treat because it spreads quickly and has a distinct biochemical makeup. However, researchers achieved a significant advance by discovering the genetic changes that occur during tumour migration -- and they also discovered a medication that may block the proc